Physician profile
Amar Patel
NPI 1841300571
$202,843.74
in general payments reported to CMS, 2019-2025
28 companies · $62K in 2025
The $62K reported for 2025 was more than what 92% of Foot and Ankle Surgery providers received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $27K · 2021: $26K · 2022: $26K · 2023: $30K · 2024: $4,389 · 2025: $62K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $73K · Consulting Fee: $15K · Travel and Lodging: $5,166 · Food and Beverage: $2,225 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $73,189.14 |
| Consulting Fee | $14,712.50 |
| Travel and Lodging | $5,165.97 |
| Food and Beverage | $2,225.02 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $125,619.02 | 2019-2025 | Ortholoc 3di Crosscheck, Variax, Bio4 |
| Wright Medical Technology, INC. | $43,674.83 | 2019-2020 | |
| Smith+Nephew, INC. | $14,011.43 | 2022-2025 | Q-Fix, Bone Anchors With Arthroscopic Delivery System, Footprint |
| Arthrex, INC. | $3,438.22 | 2024-2025 | Arthrex |
| Titan Surgical Group, LLC | $3,257.23 | 2022-2025 | |
| Linvatec Corporation | $3,118.03 | 2023-2025 | Biobrace 23mm, Hercules Suture Anchor System, Colink Mfx |
| Osteomed LLC | $2,875.00 | 2019-2020 | |
| Acumed LLC | $2,706.75 | 2023-2025 | Osteomed |
| In2bones USA, LLC | $1,090.93 | 2019-2021 | |
| International Life Sciences | $1,000.00 | 2024 | Flexband |
| Kci USA, INC. | $800.00 | 2020 | |
| Bone Support INC. | $700.00 | 2020 | |
| Polynovo North America LLC | $116.00 | 2022-2024 | Novosorb Btm |
| Zimmer Biomet Holdings, INC. | $99.37 | 2021 | |
| Heron Therapeutics, INC. | $57.19 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Theramicro, INC. | $55.68 | 2025 | Tekbrace Solo |
| Ferring Pharmaceuticals INC. | $35.95 | 2024 | Euflexxa |
| Depuy Synthes Sales INC. | $27.76 | 2022 | |
| Bioventus LLC | $26.93 | 2019 | |
| Dynasplint Systems INC. | $24.88 | 2019-2023 | Dynasplint |
| Ethicon US, LLC | $22.39 | 2019 | |
| Ossio INC | $21.76 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $19.25 | 2025 | |
| Sanofi-Aventis U.S. LLC | $18.72 | 2020 | |
| Integra Lifesciences Corporation | $14.42 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $12.00 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,281,575.35 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amar Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.